273 related articles for article (PubMed ID: 27002182)
1. Crystal structures and mutagenesis of PPP-family ser/thr protein phosphatases elucidate the selectivity of cantharidin and novel norcantharidin-based inhibitors of PP5C.
Chattopadhyay D; Swingle MR; Salter EA; Wood E; D'Arcy B; Zivanov C; Abney K; Musiyenko A; Rusin SF; Kettenbach A; Yet L; Schroeder CE; Golden JE; Dunham WH; Gingras AC; Banerjee S; Forbes D; Wierzbicki A; Honkanen RE
Biochem Pharmacol; 2016 Jun; 109():14-26. PubMed ID: 27002182
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.
Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE
J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665
[TBL] [Abstract][Full Text] [Related]
4. Insights into the key interactions between human protein phosphatase 5 and cantharidin using molecular dynamics and site-directed mutagenesis bioassays.
Liu JY; Chen XE; Zhang YL
Sci Rep; 2015 Jul; 5():12359. PubMed ID: 26190207
[TBL] [Abstract][Full Text] [Related]
5. Suppression of Ser/Thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell death.
Theobald B; Bonness K; Musiyenko A; Andrews JF; Urban G; Huang X; Dean NM; Honkanen RE
Mol Cancer Res; 2013 Aug; 11(8):845-55. PubMed ID: 23671329
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for the catalytic activity of human serine/threonine protein phosphatase-5.
Swingle MR; Honkanen RE; Ciszak EM
J Biol Chem; 2004 Aug; 279(32):33992-9. PubMed ID: 15155720
[TBL] [Abstract][Full Text] [Related]
7. Interactions of cantharidin-like inhibitors with human protein phosphatase-5 in a Mg
Assis LC; de Castro AA; Prandi IG; Mancini DT; de Giacoppo JOS; Savedra RML; de Assis TM; Carregal JB; da Cunha EFF; Ramalho TC
J Mol Model; 2018 Oct; 24(10):303. PubMed ID: 30280322
[TBL] [Abstract][Full Text] [Related]
8. Development and validation of a robust and sensitive assay for the discovery of selective inhibitors for serine/threonine protein phosphatases PP1α (PPP1C) and PP5 (PPP5C).
Swingle MR; Honkanen RE
Assay Drug Dev Technol; 2014 Oct; 12(8):481-96. PubMed ID: 25383722
[TBL] [Abstract][Full Text] [Related]
9. Inhibitors of Serine/Threonine Protein Phosphatases: Biochemical and Structural Studies Provide Insight for Further Development.
Swingle MR; Honkanen RE
Curr Med Chem; 2019; 26(15):2634-2660. PubMed ID: 29737249
[TBL] [Abstract][Full Text] [Related]
10. Crystal structure and mutagenesis of a protein phosphatase-1:calcineurin hybrid elucidate the role of the beta12-beta13 loop in inhibitor binding.
Maynes JT; Perreault KR; Cherney MM; Luu HA; James MN; Holmes CF
J Biol Chem; 2004 Oct; 279(41):43198-206. PubMed ID: 15280359
[TBL] [Abstract][Full Text] [Related]
11. Ro 90-7501 inhibits PP5 through a novel, TPR-dependent mechanism.
Hong TJ; Park K; Choi EW; Hahn JS
Biochem Biophys Res Commun; 2017 Jan; 482(2):215-220. PubMed ID: 27840051
[TBL] [Abstract][Full Text] [Related]
12. Identification and biochemical characterization of protein phosphatase 5 from the cantharidin-producing blister beetle, Epicauta chinensis.
Chen X; Lü S; Zhang Y
Int J Mol Sci; 2013 Dec; 14(12):24501-13. PubMed ID: 24351830
[TBL] [Abstract][Full Text] [Related]
13. The phosphoprotein phosphatase family of Ser/Thr phosphatases as principal targets of naturally occurring toxins.
Pereira SR; Vasconcelos VM; Antunes A
Crit Rev Toxicol; 2011 Feb; 41(2):83-110. PubMed ID: 21288162
[TBL] [Abstract][Full Text] [Related]
14. Heterocyclic substituted cantharidin and norcantharidin analogues--synthesis, protein phosphatase (1 and 2A) inhibition, and anti-cancer activity.
Hill TA; Stewart SG; Sauer B; Gilbert J; Ackland SP; Sakoff JA; McCluskey A
Bioorg Med Chem Lett; 2007 Jun; 17(12):3392-7. PubMed ID: 17451951
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling of the catalytic domain of serine/threonine phosphatase-1 with the Zn2+ and Mn2+ di-nuclear ion centers in the active site.
Wozniak E; Ołdziej S; Ciarkowski J
Comput Chem; 2000 May; 24(3-4):381-90. PubMed ID: 10816008
[TBL] [Abstract][Full Text] [Related]
16. The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.
D'Arcy BM; Swingle MR; Papke CM; Abney KA; Bouska ES; Prakash A; Honkanen RE
Mol Cancer Ther; 2019 Mar; 18(3):556-566. PubMed ID: 30679389
[TBL] [Abstract][Full Text] [Related]
17. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode.
Baba Y; Hirukawa N; Sodeoka M
Bioorg Med Chem; 2005 Sep; 13(17):5164-70. PubMed ID: 15951185
[TBL] [Abstract][Full Text] [Related]
18. Theoretical models of catalytic domains of protein phosphatases 1 and 2A with Zn2+ and Mn2+ metal dications and putative bioligands in their catalytic centers.
Woźniak-Celmer E; Ołdziej S; Ciarkowski J
Acta Biochim Pol; 2001; 48(1):35-52. PubMed ID: 11440182
[TBL] [Abstract][Full Text] [Related]
19. Cantharidin impedes the activity of protein serine/threonine phosphatase in Plutella xylostella.
Chen X; Liu J; Zhang Y
Mol Biosyst; 2014 Feb; 10(2):240-50. PubMed ID: 24253262
[TBL] [Abstract][Full Text] [Related]
20. Characterization of protein phosphatase 5 from three lepidopteran insects: Helicoverpa armigera, Mythimna separata and Plutella xylostella.
Chen X; Lü S; Zhang Y
PLoS One; 2014; 9(5):e97437. PubMed ID: 24823652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
